Riggs Asset Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-10
| Closed | – | – | 341 |
|
2022
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 336 |
|
2022
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 317 |
|
2022
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 332 |
|
2021
Q4 | $1K | Hold |
10
| – | – | ﹤0.01% | 307 |
|
2021
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 305 |
|
2021
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 305 |
|
2021
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 276 |
|
2020
Q4 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 263 |
|
2020
Q3 | – | Sell |
-10
| Closed | -$3K | – | 200 |
|
2020
Q2 | $3K | Hold |
10
| – | – | ﹤0.01% | 215 |
|
2020
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 270 |
|
2019
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 302 |
|
2019
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 253 |
|
2019
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 264 |
|
2019
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 253 |
|
2018
Q4 | $1K | Hold |
10
| – | – | ﹤0.01% | 229 |
|
2018
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 245 |
|
2018
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 260 |
|
2018
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 266 |
|
2017
Q4 | $1K | Hold |
10
| – | – | ﹤0.01% | 259 |
|
2017
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 255 |
|
2017
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 277 |
|
2017
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 258 |
|
2016
Q4 | $1K | Hold |
10
| – | – | ﹤0.01% | 251 |
|
2016
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 255 |
|
2016
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 250 |
|
2016
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 244 |
|
2015
Q4 | $1K | Hold |
10
| – | – | ﹤0.01% | 251 |
|
2015
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 245 |
|
2015
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 291 |
|
2015
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 283 |
|
2014
Q4 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 279 |
|